ChemInform Abstract: Development of FUB 181, a Selective Histamine H3-Receptor Antagonist of High Oral in vivo Potency with 4-(ω-(Arylalkyloxy)alkyl)-1H-imidazole Structure.
2020 ◽
Vol 375
(2)
◽
pp. 276-285
Keyword(s):
2012 ◽
Vol 20
(9)
◽
pp. 2889-2896
◽
Keyword(s):
2012 ◽
Vol 65
(3)
◽
pp. 115-121
◽
Keyword(s):
1996 ◽
Vol 6
(16)
◽
pp. 2013-2018
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):